{"preliminary_commentary":{"by_channel":{"x_thread":4},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. A report screens them, searches for more and cites what clinicians said when it is built, so final coverage is set at build."},"free_build":{"available":false},"name":"TIAN-SHAN1","nct_id":"NCT06905197","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=tian-shan1-nct06905197. The price is an estimate of verified HCP statements from the commentary indexed so far, fixed at order. Final coverage is set when the report is built. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_usd":750,"size":"focused","size_rule":"Focused: 1–150 verified HCP statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":null,"label":"Experimental: Part A Dose Escalation monotherapy cohorts (20 mg once daily [QD])","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Part A Dose Escalation monotherapy cohorts (40 mg QD)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Part A Dose Escalation monotherapy cohorts (60 mg QD)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Part A Dose Escalation monotherapy cohorts (90 mg QD)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Part A Dose Escalation monotherapy cohorts (120 mg QD)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Part A Dose Escalation monotherapy cohorts (150 mg QD)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Experimental: Part A Dose Escalation Combination cohorts (Combination dose 1)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Experimental: Part A Dose Escalation Combination cohorts (Combination dose 2)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Part A Dose Escalation Combination cohorts (Combination dose 3)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Part B Dose Expansion cohort A1 (selected dose 1)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Experimental: Part B Dose Expansion cohort A2 (selected dose 2)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Experimental: Part B Dose Expansion cohort B1 (selected dose 1)","type":"EXPERIMENTAL"},{"description":null,"label":"Experimental: Experimental: Part B Dose Expansion cohort B2 (selected dose 2)","type":"EXPERIMENTAL"}],"collaborators":[],"completion_date":{"date":"2028-12","type":"ESTIMATED"},"conditions":["Non Small Cell Lung Cancer"],"enrollment":{"count":140,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"DZD6008","otherNames":[],"type":"DRUG"},{"name":"Sunvozertinib","otherNames":[],"type":"DRUG"}],"last_update":"2026-02-27","lead_sponsor":"Dizal Pharmaceuticals","official_title":"A Phase 1, Open-Label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Efficacy of DZD6008 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations (TIAN-SHAN1)","overall_status":"RECRUITING","phases":["PHASE1"],"primary_completion_date":{"date":"2027-09","type":"ESTIMATED"},"primary_outcomes":[{"measure":"Part A: To assess safety and tolerability","timeFrame":"21 days after the first multiple dose"},{"measure":"Part A: To assess safety and tolerability","timeFrame":"Through the study completion, an average of around 1 year"},{"measure":"Part B: To assess anti-tumor activity","timeFrame":"Through the study completion, an average of around 1 year"}],"references":[],"start_date":{"date":"2025-05-13","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)","url":"https://clinicaltrials.gov/study/NCT06905197"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.0","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/tian-shan1-nct06905197"}